The Endometrial receptivity genome analysis (ERA) involves assessing a woman’s endometrial receptivity status from a molecular viewpoint. The molecular tool allows us to diagnose whether the endometrium is receptive or not, by analyzing the expression of a group of genes responsible for this function. This diagnostic method patented by iGenomix focuses on women who visit the clinic for their fertility problems.

With the endometrial gene expression diagnosis, problems that may affect the embryo implantation before starting the fertility treatment can be detected. As a result, corresponding measures can be taken to carry out the fertility treatment successfully. It also enables an early diagnosis of diseases originating in the endometrium.

Additional information

Nova IVI Fertility Fellowship Programme Close

Nova IVI Fertility Fellowship Programme In Reproductive Medicine

Offered at the Nova IVI Fertility Clinics in New Delhi, Chennai and Ahmedabad. Additional training will be imparted at the IVI clinics in Spain.
Duration for the Fellowship Programme is one year.
The last date for applications for our next batch is 30th November 2014. click here to view more

Consult India's leading Andrologist Close

Consult India's leading Andrologist, Dr. Rupin Shah and get all your questions on male infertility answered. Call our toll-free number 1800-103-2229